Butyrophilin-Like Protein 9 (BTNL9) Antibody (Biotin)
169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Butyrophilin-Like Protein 9 (BTNL9) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx307830
tested applications
ELISA
Description
BTNL9 Antibody (Biotin) is a Rabbit Polyclonal against BTNL9 conjugated to Biotin.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Butyrophilin-Like Protein 9 (BTNL9) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Biotin |
| Isotype | IgG |
| Purity | > 95% |
| Purification | Purified by Protein G. |
| Size 1 | 20 µg |
| Size 2 | 50 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 1 mg |
| Form | Liquid |
| Tested Applications | ELISA |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q6UXG8 |
| Gene ID | 153579 |
| NCBI Accession | NP_001295174.1, NM_001308245.1, NP_689760.2, NM_152547.4 |
| Alias | BTN3,BTN8,VDLS1900,Butyrophilin-like protein 9 |
| Background | Antibody anti-BTNL9 |
| Status | RUO |
Descripción
Butyrophilin like 9 (BTNL9) is another immunomodulatory protein in the butyrophilin-like family, with expression detected in various tissues, including epithelial barriers. Similar to BTNL8, BTNL9 is implicated in regulating immune cell activity, particularly γδ T cells, which play a pivotal role in innate immune responses and tumor surveillance. While the precise functions of BTNL9 are not fully elucidated, it is hypothesized to participate in maintaining immune homeostasis at barrier sites by modulating local immune responses to environmental antigens and pathogens. Genetic variations in BTNL9 have been linked to susceptibility to certain inflammatory diseases, highlighting its potential role in immune regulation. Further research is needed to explore its molecular interactions, potential as a biomarker for immune-related diseases, and its therapeutic relevance in immunotherapy and chronic inflammation.
Related Products
Recombinant Human BTNL9
Ver Producto
Recombinant Human BTNL9
Ver Producto